KERRI STALLINGS: Open Payments
NPI 1801535778 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 12 payments from 8 companies in 2025. Trend: 2023 $451 · 2024 $25 · 2025 $477
Food & beverage: $377Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $195 |
| Merck Sharp & Dohme LLC | 2 | $87 |
| Regeneron Healthcare Solutions, Inc. | 1 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Gilead Sciences, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $32 |
| BeOne Medicines USA, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: ERLEADA, KEYTRUDA, DARZALEX, LIBTAYO, REBLOZYL, Trodelvy, VENCLEXTA, BRUKINSA.
Industry payments across MD — which companies pay providers there.
